Immucell (ICCC) Receivables - Net (2010 - 2026)
Immucell's (ICCC) quarterly Receivables - Net came in at $3.4 million in Q4 2025, up 6462.78% YoY from $52097.0 in Q4 2024, and up 33.83% on a QoQ basis from $2.6 million in Q3 2025.
Immucell (ICCC) Receivables - Net (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Receivables - Net data on file, last reported at $3.4 million in Q4 2025.
- Quarterly Receivables - Net rose 6462.78% year-over-year to $3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (up 6462.78% YoY) and the FY2025 annual result came in at $3.4 million, down 9.34% from the prior year.
- Receivables - Net grew to $3.4 million in Q4 2025, from $2.6 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $3.4 million in Q4 2025 to a low of $52097.0 in Q4 2024.
- A 5-year average of $2.2 million and a median of $2.2 million in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2024 — Receivables - Net plunged 97.62% — and 2025, when it jumped 6462.78%.
- Tracing ICCC's Receivables - Net over 5 years: stood at $2.7 million in 2021, then tumbled by 34.73% to $1.8 million in 2022, then gained by 24.27% to $2.2 million in 2023, then sank by 97.62% to $52097.0 in 2024, then jumped by 6462.78% to $3.4 million in 2025.
- The last three Receivables - Net figures came in at $3.4 million (Q4 2025), $2.6 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.90 Mn |
| Jun 30, 2026 | 2.90 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 2.38 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 52,097.00 |
| Dec 31, 2024 | 52,097.00 |
| Sep 30, 2024 | 2.31 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Mar 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 2.19 Mn |
| Dec 31, 2023 | 2.19 Mn |